跳至主要内容
临床试验/CTRI/2020/07/026317
CTRI/2020/07/026317招募中未知

Correlation of O6-Methyl(Alkyl) Guanine-DNA Methyl(Alkyl) Transferase (MGMT/AGAT) GenePolymorphisms with Hematological Toxicity of Temozolomide in Adult Diffuse Glioma(MAGENTA study) - MAGENTA study

Tata Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Age over 18 years at time of index diagnosis.
  • 2. Newly-diagnosed diffuse glioma (grade II-IV) being treated or previously treated with RT+TMZ who develop or have developed significant hematologic toxicity defined as >=grade II thrombocytopenia and >=grade III neutropenia) as per CTCAE criteria v5.0
  • 3. Written informed consent

排除标准

  • 1. Recurrent/progressive glioma treated with salvage systemic therapies
  • 2. Patient with a previous history of severe myelosuppression due to other cause

研究者

相似试验